What is MediciNova Inc (MNOV) stock price today?

MediciNova Inc (MNOV) currently trades at $1.37 per share. The stock has a market capitalization of $67.43M and a P/E ratio of —x.

Is MNOV stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MediciNova Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is MediciNova Inc's revenue and earnings?

MediciNova Inc has trailing twelve-month (TTM) revenue of $409660.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.24.

MNOV

MediciNova Inc

NASDAQ: MNOV · HEALTHCARE · BIOTECHNOLOGY

$1.37

+0.74% today

Updated 2026-04-29

Market cap

$67.43M

P/E ratio

—

P/S ratio

164.61x

EPS (TTM)

$-0.24

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

Market cap

$67.43M

P/E ratio

—

P/S ratio

164.61x

EPS (TTM)

$-0.24

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$9.00

+556.93%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.02M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$1.00M	$0.00	$409657.00	$409660.00
Net income	$-14.07M	$-8.57M	$-11.05M	$-12.00M	$-2.80M
EPS	—	—	—	—	$-0.24
Free cash flow	$-12.92M	$-7.45M	$-10.64M	$-9.81M	$-2.02M
Profit margin	—	-857.15%	—	-2,928.78%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MNOV	$67.43M	24	4.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MediciNova Inc trades at $1.37. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $409660.00.

Frequently asked questions

What is MediciNova Inc's stock price?

MediciNova Inc (MNOV) trades at $1.37.

Is MediciNova Inc overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of MediciNova Inc (MNOV)?

The analyst target price is $9.00, representing +556.9% upside from the current price of $1.37.

What is MediciNova Inc's revenue?

TTM revenue is $409660.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio164.61x

ROE-25.50%

Beta0.61

50D MA$1.43

200D MA$1.40

Shares out0.05B

Float0.04B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MNOV vs LLY →MNOV vs JNJ →MNOV vs ABBV →Stock screener →